Combigan
Product utilizes brimonidine and timolol, indicated to lower intraocular pressure and designed to support the treatment of glaucoma or ocular hypertension.
Strengths: 0.2/0.5%
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Alpha-Adrenergic Agonist/Beta-Blocker
- Pharmacological class
Alpha-2 Adrenergic Agonist; Beta-Blocker
- Minor side effects
eye redness; burning sensation; stinging; eye irritation; dizziness
- Moderate side effects
conjunctivitis; blepharitis; visual disturbance; superficial punctate keratitis
- Dosage forms
Eye drops, solution
- Administration route
Ocular use
- Prescription status
POM
- Manufacturer
AbbVie
- Onset Time
30–60 minutes
- Duration
12–24 hours
- Age restrictions
Not for use in children or adolescents.
- Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to brimonidine; hypersensitivity to timolol; bronchial asthma; severe chronic obstructive pulmonary disease; sinus bradycardia; second or third degree atrioventricular block; cardiogenic shock
Precautions and warnings
monitor for heart rate changes; use with caution in patients with cardiovascular disease; may cause drowsiness
Serious side effects
anaphylaxis — requires immediate medical attention; bronchospasm — requires immediate medical attention; heart failure — requires immediate medical attention
Patient summary
Product utilizes brimonidine and timolol, indicated to lower intraocular pressure and designed to support the treatment of glaucoma or ocular hypertension.
Mechanism of action
This medicine works by reducing the production of fluid in the eye and increasing the drainage of eye fluid, which lowers pressure within the eye to healthy levels.
Storage instructions
Store at room temperature in a tightly closed container, away from moisture and direct light.
Drug interactions
beta-blockers; calcium channel blockers; digitalis glycosides; catecholamine-depleting drugs
Combigan
Product utilizes brimonidine and timolol, indicated to lower intraocular pressure and designed to support the treatment of glaucoma or ocular hypertension.
Editorial Notes
- Active ingredient(s): Brimonidine, Timolol
- Listed indication(s): Glaucoma, Ocular Hypertension
Available option
- 4 bottles - 0.2/0.5 %1055-0-2-0-5-pct-17874